Insider Trades56 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2026 | Sell | AZTA | Olga Pirogova | SVP and CHRO | 1,085 | $32.04 | $1.4B | -26.07% | +93.66% | $34.8K | -3.28% | — | Buy Now |
| Jul 31, 2026 | Buy | AZTA | Ephraim Starr | SVP, Gen Counsel & Secretary | 335 | $24.17 | $1.4B | -26.07% | +93.66% | $8.1K | +0.49% | — | Buy Now |
| May 15, 2026 | Sell | AZTA | Ephraim Starr | SVP, Gen Counsel & Secretary | 3,621 | $16.02 | $1.4B | -26.07% | +93.66% | $58.0K | -5.03% | — | Buy Now |
| Apr 28, 2026 | Buy | AZTA | William E. Iii Martin | President Multiomics | 17,790 | $24.24 | $1.4B | -26.07% | +93.66% | $431.2K | — | — | Buy Now |
| Nov 14, 2025 | Sell | AZTA | Ginger Zhou | SVP and GM, Multiomics | 1,118 | $29.75 | $1.4B | -26.07% | +93.66% | $33.3K | -4.17% | — | Buy Now |
| Nov 14, 2025 | Sell | AZTA | Olga Pirogova | SVP and CHRO | 1,553 | $29.75 | $1.4B | -26.07% | +93.66% | $46.2K | -8.49% | — | Buy Now |
| Nov 14, 2025 | Sell | AZTA | Lawrence Y. Lin | EVP, CFO and Treasurer | 3,039 | $29.75 | $1.4B | -26.07% | +93.66% | $90.4K | -6.60% | — | Buy Now |
| Nov 14, 2025 | Sell | AZTA | John Marotta | President and CEO | 10,980 | $29.75 | $1.4B | -26.07% | +93.66% | $326.7K | -10.36% | — | Buy Now |
| Sep 10, 2025 | Sell | AZTA | John Marotta | President and CEO | 316 | $29.41 | $1.4B | -26.07% | +93.66% | $9.3K | -0.30% | — | Buy Now |
| Aug 12, 2025 | Sell | AZTA | Ginger Zhou | SVP and GM, Multiomics | 1,085 | $28.54 | $1.4B | -26.07% | +93.66% | $31.0K | -3.89% | — | Buy Now |
| Aug 12, 2025 | Sell | AZTA | Olga Pirogova | SVP and CHRO | 1,085 | $28.54 | $1.4B | -26.07% | +93.66% | $31.0K | -5.60% | — | Buy Now |
| Aug 11, 2025 | Buy | AZTA | Lawrence Y. Lin | EVP, CFO and Treasurer | 2,500 | $27.96 | $1.4B | -26.07% | +93.66% | $69.9K | +5.75% | — | Buy Now |
| Jun 2, 2025 | Buy | AZTA | John Marotta | President and CEO | 1,000 | $25.99 | $1.4B | -26.07% | +93.66% | $26.0K | +0.94% | — | Buy Now |
| Jun 2, 2025 | Buy | AZTA | John Marotta | President and CEO | 1,000 | $25.99 | $1.4B | -26.07% | +93.66% | $26.0K | +0.94% | — | Buy Now |
| May 15, 2025 | Buy | AZTA | Ephraim Starr | SVP, Gen Counsel & Secretary | 37,779 | $26.71 | $1.4B | -26.07% | +93.66% | $1.0M | — | — | Buy Now |
| May 8, 2025 | Buy | AZTA | John Marotta | President and CEO | 5,433.803 | $27.49 | $1.4B | -26.07% | +93.66% | $149.4K | +2.65% | — | Buy Now |
| May 8, 2025 | Buy | AZTA | John Marotta | President and CEO | 5,433.803 | $27.61 | $1.4B | -26.07% | +93.66% | $150.0K | +2.67% | — | Buy Now |
| May 8, 2025 | Buy | AZTA | Lawrence Y. Lin | EVP, CFO and Treasurer | 6,000 | $27.55 | $1.4B | -26.07% | +93.66% | $165.3K | +7.79% | — | Buy Now |
| Feb 11, 2025 | Buy | AZTA | Lawrence Y. Lin | EVP, CFO and Treasurer | 2,200 | $46.00 | $1.4B | -26.07% | +93.66% | $101.2K | +6.23% | — | Buy Now |
| Feb 3, 2025 | Sell | AZTA | Violetta Hughes | VP, Chief Accounting Officer | 317 | $52.97 | $1.4B | -26.07% | +93.66% | $16.8K | -3.20% | — | Buy Now |
| Jan 31, 2025 | Buy | AZTA | Ginger Zhou | SVP and General Manager, Genom | 417 | $45.88 | $1.4B | -26.07% | +93.66% | $19.1K | +1.52% | — | Buy Now |
| Dec 5, 2024 | Buy | AZTA | Lawrence Y. Lin | EVP, CFO and Treasurer | 28,813 | $45.00 | $1.4B | -26.07% | +93.66% | $1.3M | +79.94% | — | Buy Now |
| Nov 19, 2024 | Sell | AZTA | Violetta Hughes | VP, Chief Accounting Officer | 163 | $40.07 | $1.4B | -26.07% | +93.66% | $6.5K | -1.62% | — | Buy Now |
| Nov 19, 2024 | Sell | AZTA | David Dong Wang | SVP & GM, SMS | 348 | $40.07 | $1.4B | -26.07% | +93.66% | $13.9K | -1.42% | — | Buy Now |
| Nov 19, 2024 | Sell | AZTA | Ginger Zhou | SVP and General Manager, Genom | 491 | $40.07 | $1.4B | -26.07% | +93.66% | $19.7K | -1.75% | — | Buy Now |
| Nov 19, 2024 | Sell | AZTA | Olga Pirogova | SVP and CHRO | 548 | $40.07 | $1.4B | -26.07% | +93.66% | $22.0K | -2.75% | — | Buy Now |
| Nov 19, 2024 | Sell | AZTA | Herman Cueto | EVP, Chief Financial Officer | 712 | $40.07 | $1.4B | -26.07% | +93.66% | $28.5K | -2.89% | — | Buy Now |
| Nov 19, 2024 | Sell | AZTA | Jason Joseph | SVP, General Counsel, Secy. | 1,139 | $40.07 | $1.4B | -26.07% | +93.66% | $45.6K | -1.00% | — | Buy Now |
| Nov 15, 2024 | Buy | AZTA | Violetta Hughes | VP, Chief Accounting Officer | 6,921 | $41.51 | $1.4B | -26.07% | +93.66% | $287.3K | +218.88% | — | Buy Now |
| Nov 15, 2024 | Buy | AZTA | Ginger Zhou | SVP and General Manager, Genom | 8,651 | $41.51 | $1.4B | -26.07% | +93.66% | $359.1K | +44.73% | — | Buy Now |
| Nov 15, 2024 | Buy | AZTA | David Dong Wang | SVP & GM, SMS | 8,651 | $41.51 | $1.4B | -26.07% | +93.66% | $359.1K | +54.72% | — | Buy Now |
| Nov 15, 2024 | Buy | AZTA | Olga Pirogova | SVP and CHRO | 10,381 | $41.51 | $1.4B | -26.07% | +93.66% | $430.9K | +108.82% | — | Buy Now |
| Nov 15, 2024 | Buy | AZTA | Jason Joseph | SVP, General Counsel, Secy. | 13,841 | $41.51 | $1.4B | -26.07% | +93.66% | $574.5K | +13.86% | — | Buy Now |
| Nov 15, 2024 | Buy | AZTA | John Marotta | President and CEO | 97,588.977 | $41.23 | $1.4B | -26.07% | +93.66% | $4.0M | +51.42% | — | Buy Now |
| Oct 17, 2024 | Sell | AZTA | Herman Cueto | EVP, Chief Financial Officer | 1,595 | $43.68 | $1.4B | -26.07% | +93.66% | $69.7K | -6.09% | — | Buy Now |
| Sep 9, 2024 | Buy | AZTA | John Marotta | President and CEO | 3,273 | $46.15 | $1.4B | -26.07% | +93.66% | $151.0K | — | — | Buy Now |
| Aug 9, 2024 | Buy | AZTA | Ginger Zhou | SVP and General Manager, Genom | 6,333 | $55.27 | $1.4B | -26.07% | +93.66% | $350.0K | +48.69% | — | Buy Now |
| Aug 9, 2024 | Buy | AZTA | Olga Pirogova | SVP and CHRO | 6,333 | $55.27 | $1.4B | -26.07% | +93.66% | $350.0K | +197.47% | — | Buy Now |
| Aug 9, 2024 | Buy | AZTA | David Dong Wang | SVP & GM, SMS | 6,333 | $55.27 | $1.4B | -26.07% | +93.66% | $350.0K | +66.82% | — | Buy Now |
| Aug 9, 2024 | Buy | AZTA | Jason Joseph | SVP, General Counsel, Secy. | 10,856 | $55.27 | $1.4B | -26.07% | +93.66% | $600.0K | +12.20% | — | Buy Now |
| Aug 9, 2024 | Buy | AZTA | Herman Cueto | EVP, Chief Financial Officer | 11,309 | $55.27 | $1.4B | -26.07% | +93.66% | $625.0K | +75.95% | — | Buy Now |
| Feb 1, 2024 | Buy | AZTA | Robin Vacha | SVP, GM Life Science Products | 324 | $39.41 | $1.4B | -26.07% | +93.66% | $12.8K | +1.05% | — | Buy Now |
| Feb 1, 2024 | Buy | AZTA | Ginger Zhou | SVP and General Manager, Genom | 448 | $39.41 | $1.4B | -26.07% | +93.66% | $17.7K | +3.59% | — | Buy Now |
| Jan 31, 2024 | Buy | AZTA | Ginger Zhou | SVP and General Manager, Genom | 64 | $53.01 | $1.4B | -26.07% | +93.66% | $3.4K | +0.49% | — | Buy Now |
| Jan 31, 2024 | Buy | AZTA | Robin Vacha | SVP, GM Life Science Products | 151 | $53.01 | $1.4B | -26.07% | +93.66% | $8.0K | +0.48% | — | Buy Now |
| Jan 31, 2024 | Buy | AZTA | Violetta Hughes | VP, Chief Accounting Officer | 311 | $65.20 | $1.4B | -26.07% | +93.66% | $20.3K | +9.05% | — | Buy Now |
| Nov 16, 2023 | Buy | AZTA | Violetta Hughes | VP, Chief Accounting Officer | 1,374 | $54.57 | $1.4B | -26.07% | +93.66% | $75.0K | +51.21% | — | Buy Now |
| Nov 16, 2023 | Buy | AZTA | Olga Pirogova | SVP and CHRO | 3,207 | $54.57 | $1.4B | -26.07% | +93.66% | $175.0K | — | — | Buy Now |
| Nov 16, 2023 | Buy | AZTA | David Dong Wang | SVP & GM, SMS | 3,207 | $54.57 | $1.4B | -26.07% | +93.66% | $175.0K | +50.04% | — | Buy Now |
| Nov 16, 2023 | Buy | AZTA | Herman Cueto | EVP, Chief Financial Officer | 14,890 | $54.57 | $1.4B | -26.07% | +93.66% | $812.5K | +260.00% | — | Buy Now |
| Nov 15, 2023 | Buy | AZTA | Ginger Zhou | SVP and General Manager, Genom | 4,084 | $54.48 | $1.4B | -26.07% | +93.66% | $222.5K | +22.50% | — | Buy Now |
| Nov 15, 2023 | Buy | AZTA | David C Gray | Chief Strategy & New Business | 5,166 | $54.33 | $1.4B | -26.07% | +93.66% | $280.6K | +3.34% | — | Buy Now |
| Nov 15, 2023 | Buy | AZTA | Lindon G Robertson | EVP & Chief Financial Officer | 6,297 | $54.13 | $1.4B | -26.07% | +93.66% | $340.9K | +5.36% | — | Buy Now |
| Nov 15, 2023 | Buy | AZTA | Robin Vacha | SVP, GM Life Science Products | 8,689 | $54.36 | $1.4B | -26.07% | +93.66% | $472.4K | +16.84% | — | Buy Now |
| Nov 15, 2023 | Buy | AZTA | Jason Joseph | SVP, General Counsel, Secy. | 9,057 | $54.40 | $1.4B | -26.07% | +93.66% | $492.7K | +4.50% | — | Buy Now |
| Nov 15, 2023 | Buy | AZTA | Stephen S Schwartz | CEO | 38,874 | $54.38 | $1.4B | -26.07% | +93.66% | $2.1M | +4.60% | — | Buy Now |